Houra Loghmani

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Insulin Resistance

Tyrosine Kinase

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies. Cancer immunology research (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)